Biogen
Clinical trials sponsored by Biogen, explained in plain language.
-
Can a second drug boost gene therapy in babies with SMA?
Disease control Not yet recruitingThis study tests a drug called salanersen in babies with spinal muscular atrophy (SMA) who already received gene therapy. The goal is to see if adding salanersen can improve motor skills and reduce symptoms. About 42 infants with two copies of the SMN2 gene will receive either sa…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated May 17, 2026 09:19 UTC
-
New hope for kids with MS: safer drug combo under trial
Disease control Not yet recruitingThis study tests two oral drugs, diroximel fumarate and dimethyl fumarate, in children with relapsing multiple sclerosis. About 185 kids will be split by weight and randomly assigned to one of the drugs or a standard treatment (fingolimod). The goal is to see which drug better co…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated May 17, 2026 09:18 UTC